Position in ARGX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$292,185,437
-$44,847,137 QoQ
Shares Held
400,117
-0.2% QoQ
Ownership
0.643%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 18.215172062171813.ToString("F0")%
Shared 0.ToString("F0")%
None 81.78482793782818.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. ARGX ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
This page
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $292,185,437 | 400,117 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $337,032,574 | 400,776 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $252,525,052 | 342,379 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $185,276,064 | 336,120 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $201,302,162 | 340,115 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $159,007,635 | 258,549 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $181,980,047 | 335,707 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $124,798,035 | 290,201 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $107,704,465 | 273,556 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $52,746,997 | 138,651 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $71,399,422 | 145,230 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $79,450,355 | 203,860 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $110,966,243 | 297,832 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $39,579,776 | 104,479 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,651,360 | 69,824 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,818,096 | 81,340 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $24,662,600 | 78,217 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,851,633 | 50,977 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $15,422,234 | 51,067 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,790,818 | 52,449 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $13,489,151 | 48,982 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,863,200 | 43,739 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $10,276,869 | 39,147 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,621,351 | 38,278 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,038,576 | 30,658 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||